BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 27604270)

  • 61. Biosynthesis of drug glucuronides for use as authentic standards.
    Soars MG; Mattiuz EL; Jackson DA; Kulanthaivel P; Ehlhardt WJ; Wrighton SA
    J Pharmacol Toxicol Methods; 2002; 47(3):161-8. PubMed ID: 12628307
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Quantitative distribution of mRNAs encoding the 19 human UDP-glucuronosyltransferase enzymes in 26 adult and 3 fetal tissues.
    Court MH; Zhang X; Ding X; Yee KK; Hesse LM; Finel M
    Xenobiotica; 2012 Mar; 42(3):266-77. PubMed ID: 21995321
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A Novel Liquid Chromatography Tandem Mass Spectrometry Method for the Estimation of Bilirubin Glucuronides and its Application to In Vitro Enzyme Assays.
    Putluru SP; Matta MK; Ahire D; Subramanian M; Sinz M; Mandlekar S
    Drug Metab Lett; 2017; 10(4):264-269. PubMed ID: 27908259
    [TBL] [Abstract][Full Text] [Related]  

  • 64. N-glucuronidation of the platelet-derived growth factor receptor tyrosine kinase inhibitor 6,7-(dimethoxy-2,4-dihydroindeno[1,2-C]pyrazol-3-yl)-(3-fluoro-phenyl)-amine by human UDP-glucuronosyltransferases.
    Yan Z; Caldwell GW; Gauthier D; Leo GC; Mei J; Ho CY; Jones WJ; Masucci JA; Tuman RW; Galemmo RA; Johnson DL
    Drug Metab Dispos; 2006 May; 34(5):748-55. PubMed ID: 16455802
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Characterization of hepatic and intestinal glucuronidation of magnolol: application of the relative activity factor approach to decipher the contributions of multiple UDP-glucuronosyltransferase isoforms.
    Zhu L; Ge G; Zhang H; Liu H; He G; Liang S; Zhang Y; Fang Z; Dong P; Finel M; Yang L
    Drug Metab Dispos; 2012 Mar; 40(3):529-38. PubMed ID: 22180045
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Farnesol is glucuronidated in human liver, kidney and intestine in vitro, and is a novel substrate for UGT2B7 and UGT1A1.
    Staines AG; Sindelar P; Coughtrie MW; Burchell B
    Biochem J; 2004 Dec; 384(Pt 3):637-45. PubMed ID: 15320866
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Absolute protein quantification of clinically relevant cytochrome P450 enzymes and UDP-glucuronosyltransferases by mass spectrometry-based targeted proteomics.
    Gröer C; Busch D; Patrzyk M; Beyer K; Busemann A; Heidecke CD; Drozdzik M; Siegmund W; Oswald S
    J Pharm Biomed Anal; 2014 Nov; 100():393-401. PubMed ID: 25218440
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Enzyme-assisted synthesis and structure characterization of glucuronide conjugates of methyltestosterone (17 alpha-methylandrost-4-en-17 beta-ol-3-one) and nandrolone (estr-4-en-17 beta-ol-3-one) metabolites.
    Kuuranne T; Aitio O; Vahermo M; Elovaara E; Kostiainen R
    Bioconjug Chem; 2002; 13(2):194-9. PubMed ID: 11906255
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Characterization of Hepatic UDP-Glucuronosyltransferase Enzyme Abundance-Activity Correlations and Population Variability Using a Proteomics Approach and Comparison with Cytochrome P450 Enzymes.
    Takahashi RH; Forrest WF; Smith AD; Badee J; Qiu N; Schmidt S; Collier AC; Parrott N; Fowler S
    Drug Metab Dispos; 2021 Sep; 49(9):760-769. PubMed ID: 34187837
    [TBL] [Abstract][Full Text] [Related]  

  • 70. In vitro glucuronidation kinetics of deoxynivalenol by human and animal microsomes and recombinant human UGT enzymes.
    Maul R; Warth B; Schebb NH; Krska R; Koch M; Sulyok M
    Arch Toxicol; 2015 Jun; 89(6):949-60. PubMed ID: 24927789
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Analysis of intact glucuronides and sulfates of serotonin, dopamine, and their phase I metabolites in rat brain microdialysates by liquid chromatography-tandem mass spectrometry.
    Uutela P; Reinilä R; Harju K; Piepponen P; Ketola RA; Kostiainen R
    Anal Chem; 2009 Oct; 81(20):8417-25. PubMed ID: 19772284
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Identification of human UDP-glucuronosyltransferase enzyme(s) responsible for the glucuronidation of ezetimibe (Zetia).
    Ghosal A; Hapangama N; Yuan Y; Achanfuo-Yeboah J; Iannucci R; Chowdhury S; Alton K; Patrick JE; Zbaida S
    Drug Metab Dispos; 2004 Mar; 32(3):314-20. PubMed ID: 14977865
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Determination of mRNA expression of human UDP-glucuronosyltransferases and application for localization in various human tissues by real-time reverse transcriptase-polymerase chain reaction.
    Ohno S; Nakajin S
    Drug Metab Dispos; 2009 Jan; 37(1):32-40. PubMed ID: 18838504
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Determination of drug glucuronidation and UDP-glucuronosyltransferase selectivity using a 96-well radiometric assay.
    Di Marco A; D'Antoni M; Attaccalite S; Carotenuto P; Laufer R
    Drug Metab Dispos; 2005 Jun; 33(6):812-9. PubMed ID: 15788539
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Inhibition of UDP-glucuronosyltransferase by aglycons of natural glucuronides in kampo medicines using SN-38 as a substrate.
    Yokoi T; Narita M; Nagai E; Hagiwara H; Aburada M; Kamataki T
    Jpn J Cancer Res; 1995 Oct; 86(10):985-9. PubMed ID: 7493919
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Development of an assay using 4-trifluoromethylumbelliferyl as a marker substrate for assessment of drug-drug interactions to multiple isoforms of UDP-glucuronosyltransferases.
    Baranczewski P; Kallin A; Andersson A; Hagigi S; Aberg M; Postlind H; Mankowitz L
    Assay Drug Dev Technol; 2004 Aug; 2(4):345-52. PubMed ID: 15357915
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Inhibitory potential of nonsteroidal anti-inflammatory drugs on UDP-glucuronosyltransferase 2B7 in human liver microsomes.
    Mano Y; Usui T; Kamimura H
    Eur J Clin Pharmacol; 2007 Feb; 63(2):211-6. PubMed ID: 17200831
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Human UDP-Glucuronosyltransferase (UGT) 2B10: Validation of Cotinine as a Selective Probe Substrate, Inhibition by UGT Enzyme-Selective Inhibitors and Antidepressant and Antipsychotic Drugs, and Structural Determinants of Enzyme Inhibition.
    Pattanawongsa A; Nair PC; Rowland A; Miners JO
    Drug Metab Dispos; 2016 Mar; 44(3):378-88. PubMed ID: 26669329
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Evaluation of bisphenol A glucuronidation according to UGT1A1*28 polymorphism by a new LC-MS/MS assay.
    Trdan Lušin T; Roškar R; Mrhar A
    Toxicology; 2012 Feb; 292(1):33-41. PubMed ID: 22154984
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Epirubicin glucuronidation is catalyzed by human UDP-glucuronosyltransferase 2B7.
    Innocenti F; Iyer L; Ramírez J; Green MD; Ratain MJ
    Drug Metab Dispos; 2001 May; 29(5):686-92. PubMed ID: 11302935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.